Please visit Jefferson Lab Event Policies and Guidance before planning your next event: https://www.jlab.org/conference_planning.

Mar 15 – 21, 2024
Sheraton Waterside Hotel
US/Eastern timezone

TRIUMF Accelerator Applications for the Benefit of Canada and the World

Mar 18, 2024, 1:50 PM
30m
1st Floor - Monticello (Sheraton Waterside Hotel)

1st Floor - Monticello

Sheraton Waterside Hotel

777 Waterside Dr. Norfolk, VA 23510
Invited Talk Accelerator Facilities Accelerator Facilities - 1

Speaker

Alexander Gottberg (TRIUMF)

Description

For 50 years, TRIUMF has stood at the frontier of scientific understanding as Canada’s Particle Accelerator Centre. Driven by two made-in-Canada cutting edge accelerators - the world’s largest cyclotron, and our new high-power superconducting linear accelerator - we continue to ask the big questions about the origins of the universe and everything in it.

With over five decades of experience in the production of accelerator-based secondary particles for science, TRIUMF also ensures that Canada remains on the leading edge of supplying radioisotopes, neutrons, photons, and muons enabling fundamental science in the fields of nuclear, particle and astrophysics, as well as solid state and medical applications, cancer research, electronics radiation testing and particle detector development.

ISAC-TRIUMF is the only ISOL facility worldwide that is routinely producing radioisotope beams in the high-power regime in excess of 10 kW. TRIUMF’s current flagship project ARIEL, Advanced Rare IsotopE Laboratory, will add two new target stations providing isotope beams to the existing experimental stations in ISAC I and ISAC II at keV and MeV energies, respectively. This will put TRIUMF in the capability of delivering three RIBs to different experiments, while producing radioisotopes for medical applications simultaneously – enhancing the scientific and socio-economic output of the laboratory significantly.

Together with commercial and public partners, TRIUMF generates 2M+ patient doses of medical radioisotopes per year to contribute to diagnostics and treatments of patients in Canada and worldwide. Driven by a set of in-house designed cyclotrons, delivering from 13 MeV to 500 MeV protons, a great variety of medically relevant isotopes from C-11 to Ac-225 are produced for R&D and application. Direct radiation therapy applications are developed using both, the 50-500 MeV cyclotron, as well as a 10-30 MeV electron linac. Both systems can produce ultra-high dose rate radiation pulses for Flash radiotherapy studies.

Radiation damage studies are performed in a range of radiation fields. Material displacement damage is characterized in materials for nuclear fission (SMR, ADS), fusion and accelerator applications in high dose environments. Low-dose neutron fields are used or made available to industry to study radiation effects in electronics.

Primary author

Presentation materials

There are no materials yet.